APA (7th ed.) Citation

YQ, G., DJ, L., CX, J., PP, H., CJ, Y., YT, X., . . . QQ, N. (2026). Lactylation in metabolic dysfunction-associated steatotic liver disease: Epigenetic regulatory mechanisms and potential therapeutic strategies. Biochemical pharmacology, 118193. https://doi.org/10.1016/j.bcp.2026.118193

Chicago Style (17th ed.) Citation

YQ, Guo, et al. "Lactylation in Metabolic Dysfunction-associated Steatotic Liver Disease: Epigenetic Regulatory Mechanisms and Potential Therapeutic Strategies." Biochemical Pharmacology 2026: 118193. https://doi.org/10.1016/j.bcp.2026.118193.

MLA (9th ed.) Citation

YQ, Guo, et al. "Lactylation in Metabolic Dysfunction-associated Steatotic Liver Disease: Epigenetic Regulatory Mechanisms and Potential Therapeutic Strategies." Biochemical Pharmacology, 2026, p. 118193, https://doi.org/10.1016/j.bcp.2026.118193.